PDS Biotechnology Corporation
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $26.7M | $41.7M | $56.6M | $73.8M | $65.2M | $28.8M | $12.2M | $103.7K |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $28.3M | $45.1M | $59.1M | $76.5M | $66.8M | $30.3M | $14.5M | $122.1K |
| Property, Plant & Equipment | $120.2K | $142.0K | $134.1K | $0 | $86 | $5.4K | $21.1K | $29.5K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | $3.0M | $3.0M | $0 |
| Total Assets | $30.5M | $45.4M | $59.4M | $77.0M | $67.2M | $30.9M | $14.5M | $164.4K |
| Liabilities | ||||||||
| Accounts Payable | $3.6M | $1.7M | $7.0M | $1.2M | $1.3M | $1.4M | $1.2M | $1.3M |
| Total Current Liabilities | $9.5M | $17.1M | $13.6M | $9.8M | $3.8M | $3.3M | $2.8M | $1.9M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $21.2M | $26.4M | $33.3M | $33.0M | $4.0M | $3.8M | $2.8M | $2.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-216.6M | $-182.1M | $-144.5M | $-101.6M | $-60.7M | $-43.8M | $-28.9M | $-21.9M |
| Total Stockholders' Equity | $9.3M | $19.0M | $26.1M | $44.0M | $63.2M | $27.1M | $11.7M | $-2.1M |